In a recent interview with Financial Times, Sanofi CEO Paul Hudson set out to clarify some recent comments that the US would get priority access to a…

In an interview with Financial Times correspondent Leila Abboud at the FT Global Boardroom video conference on the 14th of May, Paul Hudson, CEO of…

A compilation of the top 10 pharmaceutical companies in the Mexican pharmaceutical market based on IQVIA data from February MAT 2020. Four of the top…

The world’s two leading vaccine producers, GSK of the UK and France’s Sanofi, last week announced that they are working together to develop a…

Despite the challenging characteristics of the Romanian market, with a large population of nearly 20 million people and significant unmet medical…

Pharma industry stakeholders are generally quick to suggest that the Czech Republic is one of the most over-regulated markets in Europe, with new or…

2019 was a landmark year for the Chinese healthcare industry.* Since the publication of the ‘Healthy China 2030’ blueprint in 2016 by the Chinese…

Pascal Robin, country chair of Sanofi and general manager of Sanofi Pasteur for Romania and Moldova, shares his insights on the intrinsic and…

To celebrate International Women’s Day 2020, PharmaBoardroom brings you insights from some of the most inspirational female industry leaders we have…

Hungarian national champion Egis and French Big Pharma Sanofi have both made recent big-ticket investments in new facilities in Hungary. Egis' new…

Three seasoned pharma executives with a wealth of experience working in Brazil offer their insights on leadership strategies for success in the…

China’s pharma market is growing at an unprecedented pace and has become a key element of virtually all pharma multinationals’ international…